JNJ
JOHNSON & JOHNSON
Healthcare • CIK 0000200406
Loading...
Market Cap
$578.94B
P/E (TTM)
27.5x
Rev Growth (TTM)
+7.9%
Net Margin (TTM)
21.8%
FCF Yield (TTM)
3.1%
FCF Margin (TTM)
18.5%
Filings your agent reads
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
8-KApr 20262026-04-28source
10-QQ1 20262026-04-22source
8-KEarnings2026-04-14source
10-KFY 20252026-02-11source
8-KEarnings2026-01-21source
Point your agent at JNJ and it navigates these the same way — citing each number back to the filing.
Cash Flow Health
Free Cash Flow8/8 positive
TTM$17.8B
Q1 '27
$1.5B-73%
Q4 '26
$5.5B-32%
FCF Margin
TTM18.5%
Q1 '276.1%-73%
Sector: 0.0%Top 10%
OCF Margin23.7%
OCF/NI1.09x
CapEx Coverage4.5x
FCF Yield3.1%
FCF Growth (2Y)+3%
Cash Conversion Cycle
108 days
DSO: 66+DIO: 163−DPO: 121
Capital Allocation & Returns
Balanced
Total Shareholder YieldTTM
TTM3.5%
Div Yield2.2%
+Buyback (TTM)1.4%
Balancing returns with reinvestment
Dividend & Payout Metrics
Dividend Yield (TTM)2.2%
FCF Payout Ratio70.4%
Free Cash Flow (TTM)$17.8B
Stock Repurchases (TTM)$7.9B
Capital Return / FCF114.6%
Est. Dividends Paid (TTM)$12.5B
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
16.8%
Stable
+0.0% YoY+0.7%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
22.6%
8Q: 23.0%
Asset Turnover
0.49x
8Q: 0.50x
Leverage (1+D/E)
1.68x
D/E: 0.68x
DuPont: 18.7% ≈ 16.8% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
4.31x
8Q:4.36x
-30.3%
Invested Cap Turn
0.79x
8Q:0.80x
-8.4%
CapEx Intensity
4.2%
8Q:3.8%
CapEx/Depreciation
0.66x
Asset-based ROIC formula
Valuation Analysis
Fair Value
Price-to-EarningsTTM
27.5x
Volatile
8Q: 90.8x-32%
High PEG ratio (3.5x) suggests expensive for growth
Valuation Lenses
Earnings
27.5x
vs – sector
Cash Flow
34.1x
EV/FCF vs –
Growth-Adj
3.5xPEG
Expensive for growth
Quality-Adj
1.6P/E per %ROIC
ROIC: 16.8%
Shareholder Returns
Dividend
2.2%
Buyback
1.4%
Total Yield
3.5%
Market Cap$578.94B
EV$606.48B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
97/100
Exceptional
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Top 25%
26.4%
8Q:–
Return on Invested Capital (ROIC)Top 25%
16.8%
8Q:–
Flat
vs Sector:-0.0%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 22.6%
Asset Turnover: 0.49x
Earnings Quality
Cash Conversion
1.09x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin67.8%
Capital Efficiency
Invested Capital Turnover0.79x
Working Capital
Cash Conversion Cycle108 days
Growth Quality & Momentum
Moderate Growth
Growth Quality Score
59/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
7.9%
OpInc Growth YoY
3.2%
EPS Growth YoY
-3.9%
FCF 3Y CAGR
3.1%
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
67.8%
Operating
26.8%
Top 25% in sector
Net
21.8%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
-3.4 pts
FCF: 18.5% | Net: 21.8%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Adequate
Net Debt / EBITDA
–Net Debt: $32.94B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.68x
Balance sheet risk & solvency analysis